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Runx family transcription factors are essential 
for embryonic development and have key roles 
in hematopoiesis. They bind DNA through the 
conserved Runt domain and can activate or re-
press transcription by cooperating with other 
sequence-specific transcription factors, coactiva-
tors, and corepressors (Durst and Hiebert, 2004; 
Taniuchi and Littman, 2004). Runx1 (AML1) 
and Runx3 (AML2) are intimately linked to 
T cell fate choice and function by regulating tar-
get genes that specify CD4/CD8 development 
in the thymus and the postthymic differentiation 
of Th1, Th2, and Th17 cells. Runx1 and Runx3 
sequentially interact with the Cd4 silencer to 
block CD4 expression in double-negative and 
CD8 single-positive thymocytes (Taniuchi et al., 
2002). Runx3 facilitates CD8 T cell lineage 
choice by repressing Zbtb7b, the gene encoding 
the CD4 lineage signature transcription factor 
Th-POK (Egawa and Littman, 2008; Setoguchi 
et al., 2008) and also plays a role in mature cyto-
toxic T cells (Cruz-Guilloty et al., 2009). Runx1 
is predominant in naive CD4 T cells and tran-
siently down-regulated in response to activa-
tion. Runx1 is reexpressed under Th2 culture 
conditions (Naoe et al., 2007), whereas Th1 
cells express Runx3 (Djuretic et al., 2007; Naoe 
et al., 2007), which cooperates with T-bet to 
silence Il4 and activates Ifng expression (Djuretic 
et al., 2007). Runx1 promotes Th17 cell differ-
entiation by up-regulating Rorc, the gene en-
coding the Th17 signature transcription factor 
Ror-t, and II17 (Zhang et al., 2008). In T reg 
cells, Runx1 and the T reg signature transcrip-
tion factor Foxp3 cooperate at the protein level 
to regulate downstream target genes (Ono et al., 
2007), but the transcriptional regulation of T reg 
cell determinants by Runx proteins remains to 
be investigated.
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Runx proteins are essential for hematopoiesis and play an important role in T cell develop-
ment by regulating key target genes, such as CD4 and CD8 as well as lymphokine genes, 
during the specialization of naive CD4 T cells into distinct T helper subsets. In regulatory T 
(T reg) cells, the signature transcription factor Foxp3 interacts with and modulates the 
function of several other DNA binding proteins, including Runx family members, at the 
protein level. We show that Runx proteins also regulate the initiation and the maintenance 
of Foxp3 gene expression in CD4 T cells. Full-length Runx promoted the de novo expression 
of Foxp3 during inducible T reg cell differentiation, whereas the isolated dominant-nega-
tive Runt DNA binding domain antagonized de novo Foxp3 expression. Foxp3 expression in 
natural T reg cells remained dependent on Runx proteins and correlated with the binding of 
Runx/core-binding factor  to regulatory elements within the Foxp3 locus. Our data show 
that Runx and Foxp3 are components of a feed-forward loop in which Runx proteins 
contribute to the expression of Foxp3 and cooperate with Foxp3 proteins to regulate the 
expression of downstream target genes.
© 2009 Bruno et al. This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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the PI3K inhibitor LY294002 and the mTOR inhibitor rapa-
mycin in the induction of Foxp3. In contrast, the isolated 
Runt DNA binding domain counteracted Foxp3 induc-
tion (Fig. 1 B). IL2 is involved in iT reg differentiation and 
Il2 is a known Runx target gene (Djuretic et al., 2007; Ono 
et al., 2007), but the dominant-negative effect of Runt on 
Foxp3 induction persisted in the presence of exogenous IL2 
(Fig. S2), indicating that Runt blocks Foxp3 induction inde-
pendently of IL2 expression. Collectively, these data point to 
an involvement of Runx proteins in the induction of de 
novo Foxp3 expression.
Dominant-negative Runt domain antagonizes established 
Foxp3 expression in nT reg cells
We next analyzed the impact of antagonizing Runx func-
tion in established nT reg cells. CD4+ CD25+ LN T cells 
were sorted, activated, and transduced with Runt-IRES-
GFP (Runt) or IRES-GFP (control vector). 4 d later, GFPhigh 
cells were examined for Foxp3 expression by intracellular 
staining. Runt-transduced cells showed reduced expression 
of Foxp3 with a broad profile that ranged from negative to 
high, whereas control cells remained uniformly Foxp3 posi-
tive (Fig. 2 A). Analysis at different times after retroviral in-
fection showed that Foxp3 expression in Runt-transduced 
nT reg cells declined gradually and in a dose-dependent 
fashion (Fig. 2 B). Real time RT-PCR established that the 
reduced expression of Foxp3 protein reflected substantially 
reduced Foxp3 RNA levels in Runt-transduced GFPhigh nT 
reg cells (Fig. 2 C).
To explore the developmental history of Foxp3low  
“exT reg” cells that arose from the enforced expression of 
the dominant-negative Runt domain in nT reg cells, we 
exploited the finding that a differentially methylated region 
(DMR) upstream of Foxp3 exon 1 is unmethylated in nT 
reg cells but methylated in conventional T cells (Floess et al., 
2007; Kim and Leonard, 2007). GFPhigh Foxp3high and Foxp3low 
cells were isolated by cell sorting 5 d after transduction of 
nT reg cells with Runt-IRES-GFP. Genomic DNA was ana-
lyzed for the CpG methylation status of the Foxp3 DMR by 
bisulfite sequencing (CpG dinucleotides in intron 7 that are 
methylated in both conventional and nT reg cells served as 
a control). We found that the DMR was unmethylated in 
Runt-transduced Foxp3high and Foxp3low exT reg cells and 
in freshly isolated control nT reg cells. This indicated that 
Foxp3low cells arose from nT reg cells with an unmethylated 
DMR and that the Runt-mediated down-regulation of 
Foxp3 did not result in the remethylation of the DMR 
within the time frame of our analysis. The DMR remained 
fully methylated in Runt-transduced conventional CD4 
T cells, excluding the formal possibility that enforced Runt 
expression itself might cause DMR demethylation (Fig. 2 D). 
We conclude from these data that the dominant-negative 
Runt domain interferes with the maintenance of Foxp3 
expression in established nT reg cells and, therefore, that 
Runx proteins are likely regulators of Foxp3 expression in 
nT reg cells.
These data prompted us to explore the role of Runx pro-
teins in the regulation of Foxp3 in conventional CD4 T cells 
and in natural T reg (nT reg) cells. We find that the overex-
pression of Runt, the isolated Runx DNA binding domain 
with dominant-negative activity, interfered with de novo ex-
pression of Foxp3 in conventional CD4 T cells induced by 
TGF- and other signals that drive induced T reg (iT reg) 
cell differentiation. Interestingly, Runt also interfered with 
Foxp3 expression by established nT reg cells. The conditional 
ablation of core-binding factor  (Cbfb), the gene encoding the 
shared  subunit of Runx protein complexes, resulted in a 
progressive decline of Foxp3 expression by nT reg cells. 
Consistent with a role for Runx complexes in the regulation 
Foxp3, Cbfb binds to regulatory elements within the Foxp3 
locus in T reg cells but not in conventional CD4 T cells. 
Runx proteins therefore contribute to the induction and the 
maintenance of Foxp3 expression. Because Foxp3 cooperates 
with Runx proteins in the regulation of target genes (Ono 
et al., 2007), our finding that Runx itself regulates Foxp3 ex-
pression suggests that Runx and Foxp3 are components of a 
feed-forward loop, in which Runx proteins act first as regu-
lators of Foxp3 expression and subsequently as interaction 
partners of Foxp3.
RESULTS AND DISCUSSION
Runx3 promotes de novo Foxp3 expression
Naive CD4 T cells (CD4+ CD25 CD62Lhigh) were isolated 
and depleted of preexisting T reg cells by flow cytometry. 
After overnight activation with beads coated with anti-CD3/
CD28, the cells were transduced with Runx3-IRES-GFP 
(Runx3), Runx3 DNA binding domain–IRES-GFP (Runt), 
or control IRES-GFP (vector) retroviruses. 0.3 ng/ml TGF- 
was added 24 h after retroviral transduction, and Foxp3 ex-
pression was assessed 2 d later by intracellular staining. Full-
length Runx3 synergized with TGF- in promoting de novo 
Foxp3 expression in a dose-dependent fashion, as judged by 
gating on cells with increasing levels of Runx3-IRES-GFP 
expression (Fig. 1 A). Only modest levels of expression were 
achieved with the closely related Runx1, which did not con-
sistently promote Foxp3 induction (Fig. S1 and not depicted). 
Because the overexpression of transcription factors does not 
necessarily indicate physiological significance, we tested the 
impact of the isolated Runt DNA binding domain. Runt acts 
as a dominant negative for endogenous Runx proteins, pre-
sumably by competing for access to Runx DNA binding sites 
(Durst and Hiebert, 2004; Telfer et al., 2004). Runt expres-
sion antagonized the induction of Foxp3 in conventional 
CD4 T cells in a dose-dependent manner (Fig. 1 A). De 
novo Foxp3 expression in newly activated CD4 T cells can 
be induced not only by TGF- but also by the premature 
termination of TCR signaling and by inhibitors of phos-
phatidyl inositol 3 kinase (PI3K) and the mammalian target 
of rapamycin (mTOR; Gao et al., 2007; Bruno and 
Merkenschlager, 2008; Haxhinasto et al., 2008; Sauer et al., 
2008), a signaling network downstream of the TCR. Full-
length Runx3 synergized with TCR signal deprivation and 
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Figure 1. Foxp3 induction is promoted by full-length Runx3 and antagonized by the expression of dominant-negative Runt domain  
proteins. (A) Naive CD4 T cells were activated for 18 h with anti-CD3/anti-CD28 beads and retrovirally transduced with Runx3-IRES-GFP (Runx3), Runt-
IRES-GFP (Runt), or control-IRES-GFP (vector). After 24 h, 0.3 ng/ml TGF- was added and Foxp3 expression was assessed 48 h later by intracellular stain-
ing after gating on the level of GFP expression (negative [neg], low, medium [med], or high). Data are representative of four independent experiments.  
(B) Naive CD4 T cells were activated and retrovirally transduced as in A. After 24 h, the anti-CD3/anti-CD28 beads were removed (TCR depriv.) and TGF- 
or rapamycin and LY294002 (R+LY) were added as indicated. Foxp3 expression was assessed 48 h later by intracellular staining after gating on the level of 
GFP expression (negative, low, medium, or high). Data are representative of four independent experiments.
Genetic evidence for a role of Runx proteins  
in the maintenance of Foxp3 expression in nT reg cells
The activity of Runx proteins depends on the non-DNA 
binding subunit Cbfb (Durst and Hiebert, 2004), and we used 
the conditional deletion of Cbfb to probe the role of Runx 
proteins in the maintenance of Foxp3 expression in nT reg 
cells. CD4+ CD25+ LN T cells were sorted from control 
Cbfbwt/wt and Cbfblox/lox mice (Naoe et al., 2007), activated, 
and retrovirally transduced with vector-IRES-GFP or Cre-
IRES-GFP. The impact of Cre-mediated Cbfb deletion was 
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Figure 2. Runx proteins control the maintenance of Foxp3 expression in established T reg cells. (A) CD4+ CD25+ LN T cells were sorted, activated 
for 18 h with anti-CD3/anti-CD28 beads in the presence of IL-2, and retrovirally transduced. Histograms show GFP expression (left) and Foxp3 expression 
(right) in GFPhigh cells 4 d after transduction with vector-IRES-GFP (black line, right histogram) or Runt-IRES-GFP (red line, right histogram). Data are rep-
resentative of five independent experiments. (B) CD4+ CD25+ LN T cells were sorted, activated, and retrovirally transduced with Runx3-IRES-GFP (black) or 
Runt-IRES-GFP (red), and Foxp3 expression was assessed on the indicated days by intracellular staining and gating on the level of GFP (negative, low, 
medium, or high as defined in A). Data are mean ± SE of two independent experiments. (C) CD4+ CD25+ LN T cells were sorted, activated, and retrovirally 
transduced with IRES-GFP (vector) or Runt-IRES-GFP (Runt). 5 d later, GFPhigh cells were sorted and analyzed for Foxp3 RNA expression by real time  
RT-PCR. Data are mean ± SD of five independent experiments. (D) Runt-transduced T reg cells with down-regulated Foxp3 expression have a demethylated 
Foxp3 DMR, which is consistent with a history of Foxp3 expression. CD4+ CD25+ LN T cells were sorted, activated, and transduced with Runt-IRES-GFP 
(Runt). 5 d later, GFPhigh Foxp3high and Foxp3low cells were sorted and analyzed for the methylation status of the indicated regions in the Foxp3 locus by 
bisulfite sequencing. A schematic of the locus with coding (filled rectangles) and noncoding exons (open rectangles) is shown on top. Each chain of circles 
represents one sequenced allele with methylated (filled circles) and unmethylated CpG dinucleotides (open circles). The positions of CpG dinucleotides are 
indicated (Floess et al., 2007).
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monitored by intracellular Foxp3 staining 4 d later and 
showed a selective decline in Cbfblox/lox cells transduced with 
Cre-IRES-GFP (red). Foxp3 expression remained unaffected 
in vector-transduced Cbfblox/lox cells (Fig. 3 A, black) and in 
Cbfbwt/wt cells transduced with either vector-IRES-GFP 
(Fig. 3 A, black) or Cre-IRES-GFP (Fig. 3 A, red). This ef-
fect was quantified as the ratio of Foxp3 expression in GFP+ 
Cre-transduced versus vector-transduced Cbfblox/lox (Fig. 3 B, 
red) and Cbfbwt/wt (Fig. 3 B, black) cells between 2 and 5 d 
after retroviral transduction and showed a progressive decline 
in Cre-transduced Cbfblox/lox nT reg cells (Fig. 3 B, red) but 
not in Cbfbwt/wt nT reg cells (Fig. 3 B, black; mean ± SD; 
n = 3). The effective deletion of the floxed Cbfb locus was 
monitored by genomic PCR (Fig. 3 C) and Cbfb protein ex-
pression by Western blotting (Fig. 3 D). These genetic data 
and the results obtained with the dominant-negative Runt 
domain make a strong case that Runx complexes are required 
for the maintenance of Foxp3 expression in nT reg cells.
The Foxp3 locus as a target of Runx/Cbfb
The experiments described in the previous sections link 
Runx proteins with the control of Foxp3 expression. To in-
vestigate whether this link is likely to be direct, we performed 
chromatin immunoprecipitation (ChIP) experiments using 
an antibody to Cbfb (Naoe et al., 2007), the shared subunit 
of all Runx protein complexes (Durst and Hiebert, 2004). 
We detected strong binding at the TCR- chain enhancer, a 
known target of Runx/Cbfb binding (Naoe et al., 2007) in 
naive CD4 T cells and in ex vivo–isolated nT reg cells (Fig. 4 A). 
No binding was observed at the promoter of a negative con-
trol locus, Myf5 (Fig. 4 A). Interestingly, the Foxp3 promoter, 
which contains four predicted Runx binding sites (RBSs), 
was associated with Runx/Cbfb selectively in T reg cells 
but not in naive CD4 T cells (Fig. 4 A). T reg cell–specific 
Runx/Cbfb binding was also found at the predicted RBSs 
5 and 7/8, whereas other potential Runx sites and a control site 
in intron 7 showed less binding (Fig. 4 A). Finally, Cbfb ChIP 
showed enrichment around the DMR upstream of Foxp3 exon 
1 (primers intron 2.1, DMR, and intron 2.2). Further analysis 
by DNaseI footprinting showed that, compared with naive CD4 
T cells, ex vivo–isolated nT reg cells had increased DNaseI 
Figure 3. Genetic evidence for a role of Runx proteins in the 
maintenance of Foxp3 expression in nT reg cells. (A) CD4+ CD25+ LN  
T cells were sorted from control Cbfbwt/wt and Cbfblox/lox mice, activated for 
18 h with anti-CD3/anti-CD28 beads in the presence of IL-2, and retrovi-
rally transduced with vector-IRES-GFP (vector) or Cre-IRES-GFP (Cre). 4 d 
later, Foxp3 expression had declined selectively in Cbfblox/lox cells trans-
duced with Cre-IRES-GFP (red). Foxp3 expression remained unaffected in 
vector-transduced Cbfblox/lox cells (black) and in Cbfbwt/wt cells transduced 
with either vector-IRES-GFP (black) or Cre-IRES-GFP (red). Data are repre-
sentative of three independent experiments. (B) Time course of Foxp3 
expression by GFP+ Cre-IRES-GFP–transduced relative to vector-IRES-
GFP–transduced Cbfblox/lox nT reg cells (red) and Cbfbwt/wt nT reg cells 
(black; mean ± SD of three independent experiments). (C) GFP-positive 
and -negative nT reg cells were sorted 4 d after transduction with vector-
IRES-GFP (vector) or Cre-IRES-GFP (Cre), and Cbfb loci were analyzed by 
genomic PCR. The position of bands corresponding to the wild-type (wt), 
floxed (lox), and deleted () locus are indicated. One of three independent 
experiments is shown. (D) GFP-positive and -negative Cbfblox/lox cells were 
sorted 4 d after transduction with vector-IRES-GFP (vector) or Cre-IRES-
GFP (Cre), and Cbfb protein expression was analyzed by Western blotting. 
Tubulin was used as a loading control. One of three independent experi-
ments is shown.
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Figure 4. Runx and Foxp3 as components of a feed-forward loop. (A) Cbfb ChIP in naive CD4 T cells (gray bars) and ex vivo–isolated T reg cells 
(black bars). The Tcrb enhancer (enh.) and Myf5 promoter (prom.) are used as positive and negative controls, respectively. Predicted RBSs are indicated, 
and sites 2, 3, 4, and 5 are conserved between mouse and human. Regions within the Foxp3 locus examined for Cbfb binding are indicated in red. IgG is 
used instead of anti-Cbfb as a ChIP control. The region examined by footprint analysis is in blue. PCR signals are normalized to input and shown relative 
to the positive control site Tcrb enh. (mean ± SD; n = 3 independent experiments). (B) DNaseI (left) and DMS footprinting (right) of the Foxp3 promoter 
region. G, G sequencing reaction; in vitro, naked DNA; naive T, naive CD4 T cells; T reg, ex vivo–isolated T reg cells; 3T3, NIH 3T3 cells; M, macrophages. 
Base positions are shown relative to the Foxp3 transcription start site. Note that T reg cells show increased DNaseI accessibility of the Foxp3 promoter 
(stronger bands in the T reg sample) but not of a control region on chromosome 1. Vertical lines indicate local DNaseI sensitivity in T reg cells. Open  
circles indicate DMS-protected (weaker) bands in T reg cells, which may indicate the position of DNA binding proteins. A predicted Runx site is indicated. 
Data are representative of an extensive analysis of both forward and reverse strands with primers for the proximal and distal Foxp3 promoter region us-
ing independent template preparations for DNaseI and DMS treatment. (C) Scheme of a feed-forward loop where X regulates Y and X and Y together 
regulate Z. (D) Model describing a relationship between Runx and Foxp3 where Runx acts on Foxp3 expression and Foxp3 either blocks Runx activity,  
converts Runx from an activator into a repressor, or cooperates with Runx to activate or repress downstream target genes.
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of iT reg differentiation, such as TGF- or PI3K/mTOR in-
hibitors, result in the reexpression of Runx1 as well as moder-
ate Runx3 expression (Fig. S3). Runx proteins are known to 
physically interact with Foxp3 protein in established T reg 
cells (Ono et al., 2007), providing one mechanism by which 
Runt may affect nT reg cells. However, our data that Runx3 
promotes iT reg cell differentiation by increasing the fre-
quency of conventional CD4 T cells that initiate the expres-
sion of Foxp3 clearly show an impact of Runx proteins on 
Foxp3 expression by previously Foxp3 negative cells. This 
function is novel and distinct from the known role of Runx 
proteins as interactors of Foxp3 protein in nT reg cells (Ono 
et al., 2007). Together with the T reg cell–specific binding of 
Runx/Cbfb at the Foxp3 locus, these data argue that Runx 
proteins are bona fide regulators of Foxp3 expression.
MATERIALS AND METHODS
Mouse strains, cell sorting, culture, and viral infections. Animal work 
was performed according to the Animals (Scientific Procedures) Act under 
the authority of project licences PPL70/5936 and PPL70/6845 issued by the 
Home Office, UK. Naive CD4+ CD25 CD62Lhigh LN T cells or CD4+ 
CD25+ T reg cells were sorted by flow cytometry and activated at 106/ml 
either with 200 ng/ml of plate-bound anti–TCR- (H57) and 2 µg/ml of 
anti-CD28 (BD) or with anti-CD3/CD28 beads (Invitrogen) as previously 
described (Sauer et al., 2008). Exogenous IL2 was added where indicated. 
Activated T cells were retrovirally transduced with control mouse stem cell 
virus–IRES-GFP or Runx vectors (Telfer et al., 2004) by spin infection 
(90 min, 2,500 rpm, 35°C, no polybrene). Where indicated, activated cells were 
deprived of TCR signals by removing anti-CD3/CD28 beads or by moving 
the cells to fresh wells not coated with anti-TCR. 10 µg/ml LY294002, 
25 nM rapamycin, or TGF- was added as indicated. Cells were fixed and 
permeabilized (eBioscience) and stained with CD4 (Invitrogen) and Foxp3 
as advised (eBioscience). Retrovirally transduced cells were fixed for 24 h to 
improve the retention of GFP. T reg cells from Cbfblox/lox mice (Naoe et al., 
2007) were isolated by flow cytometry, activated, and infected with Cre-
IRES-GFP or control IRES-GFP retrovirus. Deletion of Cbfb exon 5 was 
monitored by genomic PCR (Naoe et al., 2007) and Foxp3 expression was 
evaluated by intracellular staining.
Immunoblotting. Immunoblotting was done as previously described (Sauer 
et al., 2008) using rabbit anti-Runx1/3 (Hayashi et al., 2000; gift from 
M. Satake, Tohoku University, Sendai, Japan) and donkey anti–rabbit IgG-HPR 
(GE Healthcare). Lamin (Santa Cruz Biotechnology, Inc.) or tubulin (Sigma-
Aldrich) antibodies were used as loading controls.
Real time RT-PCR. Total RNA was isolated using RNA-Bee (Tel-Test, 
Inc.) and reverse transcribed. PCR reactions included 2× SYBR PCR Mas-
ter Mix (QIAGEN), 300 nM of primers, and 2 µl of complementary DNA 
as a template in a 50-µl reaction volume. Cycle conditions were 94° C for 
8 min, 40 cycles of 94° C for 30 s, 55° C for 30 s, and 72° C for 1 min, fol-
lowed by plate read. All primers amplified specific complementary DNAs 
with at least 95% efficiency. Data were normalized to the geometrical mean 
of two housekeeping genes, using the CT method as outlined in the Applied 
Biosystems protocol for RT-PCR (Sauer et al., 2008). Primer sequences 
were the following: Ywhaz, forward 5-CGTTGTAGGAGCCCGTAGGT-
CAT-3 and reverse 5-TCTGGTTGCGAAGCATTGGG-3; Ube, forward 
5-AGGAGGCTGATGAAGGAGCTTGA-3 and reverse 5-TGGTTT-
GAATGGATACTCTGCTGGA-3; Runx1, forward 5-GCCTCCTTG-
AACCACTCCAC-3 and reverse 5-GTTCTGCAGAGAGGCTGGTC-3; 
Runx3, forward 5-CGACCGCTTTGGAGACCTGC-3 and reverse 5-GCG-
TAGGGAAGGAGCGGTCA-3; Cbfb, forward 5-GGACCAGAGGAG-
CAAGTTCG-3 and reverse 5-CTGGAGAGACAGATTGGTTC-3; and 
accessibility of the Foxp3 promoter, which was visible as stron-
ger bands in T reg samples (Fig. 4 B). This increased accessibil-
ity was selective because a control region on chromosome 1 was 
equally accessible in T reg cells and naive CD4 T cells. DMS 
footprinting showed protected (i.e., weaker) bands in T reg cells 
compared with naive CD4 T cells, which is indicative of the 
presence of DNA binding proteins in T reg cells (Fig. 4 B). 
One of the DMS-protected bands is within a predicted RBS in 
the Foxp3 promoter, 52 bp upstream of the Foxp3 transcription 
start site. These data establish the Foxp3 locus as a direct target 
for Runx/Cbfb in T reg cells.
Runx and Foxp3 as regulatory circuit components
Because Foxp3 protein cooperates with Runx proteins in the 
control of target genes (Ono et al., 2007), our demonstration 
that Foxp3 is itself regulated by Runx proteins points to a regu-
latory circuit in which Runx proteins are both inducers and 
interaction partners of Foxp3. Genetic feed-forward loops are 
significant network motifs in both prokaryotes and eukaryotes 
(Mangan and Alon, 2003) and involve two transcription fac-
tors: X regulates the expression of Y and both factors together 
regulate one or more downstream targets Z (Fig. 4 C). In the 
case described here, X is a Runx family transcription factor and 
Y is Foxp3. Runx and Foxp3 interact at regulatory DNA se-
quences or independently of DNA to control the expression of 
target genes (Fig. 4 D) like Il2 and Ifng (Ono et al., 2007). 
Feed-forward regulation is a recurring theme in the biology of 
Foxp3, which interacts not only with Runx but also with other 
transcription factors including Ror-t (Ichiyama et al., 2008; 
Zhou et al., 2008) and NFAT (Wu et al., 2006). Runx1 and 
Foxp3 both interact with Ror-t, indicating the potential for a 
complex regulatory network (Ichiyama et al., 2008; Zhou et al., 
2008), and NFAT, like Runx, contributes to the regulation of 
Foxp3 expression (Mantel et al., 2006; Wu et al., 2006; Tone 
et al., 2008). Foxp3 replaces the NFAT partner AP1 (Wu et al., 
2006) and, together, NFAT and Foxp3 regulate target genes 
both positively (Ctla4 and Il2ra) and negatively (Il2 and Ifng; 
Mantel et al., 2006). Depending on the sign of regulation be-
tween their elements, feed-forward circuits have the potential 
to fine-tune gene expression levels and to determine response 
parameters like on/off kinetics (Mangan and Alon, 2003). The 
identification of Foxp3 as a recurring element of feed-forward 
loops that involve transcription factors controlling T cell func-
tion suggests a distinct perspective, namely that Foxp3 subverts 
T cell regulatory circuits to establish T reg cell–specific gene 
activation and repression programmes.
Concluding remarks
Our experiments show that Runx proteins play an important 
role in the transcriptional regulation of Foxp3 during the in-
duction of Foxp3 in conventional CD4 T cells and the main-
tenance of Foxp3 expression in established T reg cells. Our 
experiments do not speak to the relative contribution of Runx 
family members. However, Runx1 is predominant in nT reg 
cells as well as in naive CD4 T cells (Fig. S3). Runx1 is down-
regulated after activation (Djuretic et al., 2007), but inducers 
 o
n
 O
ctober 12, 2011
jem.rupress.org
D
ow
nloaded from
 
Published October 19, 2009
2336 RUNX PROTEINS REGULATE FOXP3 EXPRESSION | Bruno et al.
shows that overexpression of Runt blocks Foxp3 induction in the presence 
as well as in the absence of exogenous IL-2. Fig. S3 summarizes the expres-
sion of Runx1 and Runx3 proteins in freshly isolated and cultured T cells 
and relates Runx expression to inducible Foxp3 expression.
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